Reviewed,
UniProtKB/Swiss-Prot P16949 (STMN1_HUMAN)
Last modified
January 19, 2010.
Version 113.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Stathmin Alternative name(s): Phosphoprotein p19 Short name=pp19 Leukemia-associated phosphoprotein p18 Oncoprotein 18 Short name=Op18 pp17 Prosolin Metablastin Protein Pr22 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 149 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear By similarity. |
| Subunit structure | Binds to two alpha/beta-tubulin heterodimers. Interacts with KIST. Ref.15 Ref.16 |
| Subcellular location | |
| Tissue specificity | Ubiquitous. Expression is strongest in fetal and adult brain, spinal cord, and cerebellum, followed by thymus, bone marrow, testis, and fetal liver. Expression is intermediate in colon, ovary, placenta, uterus, and trachea, and is readily detected at substantially lower levels in all other tissues examined. Lowest expression is found in adult liver. Ref.18 |
| Induction | Down-regulated in response to enterovirus 71 (EV71) infection (at protein level). Ref.22 |
| Post-translational modification | Many different phosphorylated forms are observed depending on specific combinations among the sites which can be phosphorylated. MAPK is responsible for the phosphorylation of stathmin in response to NGF. Phosphorylation at Ser-16 seems to be required for neuron polarization By similarity. Phosphorylation at Ser-63 reduces tubulin binding 10-fold and suppresses the MT polymerization inhibition activity. Ref.11 Ref.12 Ref.13 Ref.14 Ref.17 Ref.19 Ref.20 Ref.21 Ref.23 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28 Ref.29 Ref.31 Ref.32 |
| Involvement in disease | Present in much greater abundance in cells from patients with acute leukemia of different subtypes than in normal peripheral blood lymphocytes, non-leukemic proliferating lymphoid cells, bone marrow cells, or cells from patients with chronic lymphoid or myeloid leukemia. |
| Sequence similarities | Belongs to the stathmin family. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed | ||||||
| Chain | 2 – 149 | 148 | Stathmin | PRO_0000182389 | |||||
Regions | |||||||||
| Coiled coil | 41 – 140 | 100 | Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.11 Ref.31 | ||||||
| Modified residue | 9 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 16 | 1 | Phosphoserine Ref.13 Ref.14 Ref.21 Ref.23 Ref.24 Ref.25 Ref.26 Ref.28 Ref.29 Ref.31 Ref.32 | ||||||
| Modified residue | 25 | 1 | Phosphoserine; by CDC2 and MAPK Ref.11 Ref.12 Ref.13 Ref.14 Ref.19 Ref.20 Ref.21 Ref.23 Ref.24 Ref.25 Ref.26 Ref.28 Ref.29 Ref.31 Ref.32 | ||||||
| Modified residue | 28 | 1 | Phosphoserine Ref.26 | ||||||
| Modified residue | 38 | 1 | Phosphoserine; by CDC2 Ref.11 Ref.12 Ref.13 Ref.14 Ref.21 Ref.23 Ref.24 Ref.25 Ref.26 Ref.27 Ref.29 Ref.31 Ref.32 | ||||||
| Modified residue | 46 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 63 | 1 | Phosphoserine; by PKA Ref.17 Ref.21 Ref.24 Ref.26 Ref.29 | ||||||
| Modified residue | 80 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 95 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 100 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 119 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 128 | 1 | N6-acetyllysine Ref.33 | ||||||
| Modified residue | 146 | 1 | Phosphothreonine Ref.26 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species." Zhu X.-X., Kozarsky K., Strahler J.R., Eckerskorn C., Lottspeich F., Melhem R., Lowe J., Fox D.A., Hanash S.M., Atweh G.F. J. Biol. Chem. 264:14556-14560(1989) [PubMed: 2760073] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 45-61. |
| [2] | "A single amino acid difference distinguishes the human and the rat sequences of stathmin, a ubiquitous intracellular phosphoprotein associated with cell regulations." Maucuer A., Doye V., Sobel A. FEBS Lett. 264:275-278(1990) [PubMed: 2358074] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia." Melhem R.F., Zhu X., Hailat N., Strahler J.R., Hanash S.M. J. Biol. Chem. 266:17747-17753(1991) [PubMed: 1917919] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "Transcriptional and post-transcriptional regulation of pr22 (Op18) with proliferation control." Hosoya H., Ishikawa K., Dohi N., Marunouchi T. Cell Struct. Funct. 21:237-243(1996) [PubMed: 8906359] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [6] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [9] | Lubec G., Vishwanath V., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 14-41 AND 44-52, MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex. |
| [10] | "Ca2+-dependent and cAMP-dependent control of nicotinic acetylcholine receptor phosphorylation in muscle cells." Hanash S.M., Strahler J.R., Kuick R., Chu E.H.Y., Nichols D. J. Biol. Chem. 264:12813-12819(1989) [PubMed: 2546936] [Abstract] Cited for: PROTEIN SEQUENCE OF 87-96. |
| [11] | "Analysis of phosphoprotein p19 by liquid chromatography/mass spectrometry. Identification of two proline-directed serine phosphorylation sites and a blocked amino terminus." Labdon J.E., Nieves E., Schubart U.K. J. Biol. Chem. 267:3506-3513(1992) [PubMed: 1737801] [Abstract] Cited for: ACETYLATION AT ALA-2, PHOSPHORYLATION AT SER-25 AND SER-38, MASS SPECTROMETRY. |
| [12] | "Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase." Marklund U., Brattsand G., Shingler V., Gullberg M. J. Biol. Chem. 268:15039-15047(1993) [PubMed: 8325880] [Abstract] Cited for: PHOSPHORYLATION AT SER-25 AND SER-38. |
| [13] | "Multiple signal transduction pathways induce phosphorylation of serines 16, 25, and 38 of oncoprotein 18 in T lymphocytes." Marklund U., Brattsand G., Osterman O., Ohlsson P.-I., Gullberg M. J. Biol. Chem. 268:25671-25680(1993) [PubMed: 8245003] [Abstract] Cited for: PHOSPHORYLATION AT SER-16; SER-25 AND SER-38. |
| [14] | "Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38." Brattsand G., Marklund U., Nylander K., Roos G., Gullberg M. Eur. J. Biochem. 220:359-368(1994) [PubMed: 8125092] [Abstract] Cited for: PHOSPHORYLATION AT SER-16; SER-25 AND SER-38. |
| [15] | "Op18/stathmin caps a kinked protofilament-like tubulin tetramer." Steinmetz M.O., Kammerer R.A., Jahnke W., Goldie K.N., Lustig A., van Oostrum J. EMBO J. 19:572-580(2000) [PubMed: 10675326] [Abstract] Cited for: INTERACTION WITH TUBULIN. |
| [16] | "Probing the native structure of stathmin and its interaction domains with tubulin. Combined use of limited proteolysis, size exclusion chromatography, and mass spectrometry." Redeker V., Lachkar S., Siavoshian S., Charbaut E., Rossier J., Sobel A., Curmi P.A. J. Biol. Chem. 275:6841-6849(2000) [PubMed: 10702243] [Abstract] Cited for: INTERACTION WITH TUBULIN. |
| [17] | "Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin." Steinmetz M.O., Jahnke W., Towbin H., Garcia-Echeverria C., Voshol H., Mueller D., van Oostrum J. EMBO Rep. 2:505-510(2001) [PubMed: 11415983] [Abstract] Cited for: EFFECT OF PHOSPHORYLATION AT SER-63 ON TUBULIN BINDING. |
| [18] | "Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP." Bieche I., Maucuer A., Laurendeau I., Lachkar S., Spano A.J., Frankfurter A., Levy P., Manceau V., Sobel A., Vidaud M., Curmi P.A. Genomics 81:400-410(2003) [PubMed: 12676564] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [19] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, MASS SPECTROMETRY. |
| [20] | "Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry." Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., Watts J.D., Hood L., Aebersold R. Nat. Methods 2:591-598(2005) [PubMed: 16094384] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, MASS SPECTROMETRY. Tissue: T-cell. |
| [21] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25; SER-38 AND SER-63, MASS SPECTROMETRY. Tissue: Epithelium. |
| [22] | "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection." Leong W.F., Chow V.T. Cell. Microbiol. 8:565-580(2006) [PubMed: 16548883] [Abstract] Cited for: INDUCTION, MASS SPECTROMETRY. |
| [23] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25 AND SER-38, MASS SPECTROMETRY. Tissue: Epithelium. |
| [24] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25; SER-38 AND SER-63, MASS SPECTROMETRY. Tissue: Epithelium. |
| [25] | "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction." Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R. Mol. Cell. Proteomics 6:1952-1967(2007) [PubMed: 17693683] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25 AND SER-38, MASS SPECTROMETRY. |
| [26] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25; SER-28; SER-38; SER-63 AND THR-146, MASS SPECTROMETRY. |
| [27] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, MASS SPECTROMETRY. |
| [28] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-25, MASS SPECTROMETRY. |
| [29] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25; SER-38 AND SER-63, MASS SPECTROMETRY. |
| [30] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [31] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25 AND SER-38, MASS SPECTROMETRY. |
| [32] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-25 AND SER-38, MASS SPECTROMETRY. Tissue: T-cell. |
| [33] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-80; LYS-95; LYS-100; LYS-119 AND LYS-128, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | J04991 mRNA. Translation: AAA59980.1. M31303 Genomic DNA. Translation: AAA59971.1. X53305 mRNA. Translation: CAA37391.1. Z11566 mRNA. Translation: CAA77660.1. X94912 Genomic DNA. Translation: CAA64398.1. AK311801 mRNA. Translation: BAG34744.1. AL033528 Genomic DNA. Translation: CAC16020.1. CH471059 Genomic DNA. Translation: EAX07854.1. BC082228 mRNA. Translation: AAH82228.1. |
| IPI | IPI00479997. |
| PIR | A40936. |
| RefSeq | NP_005554.1. NP_981944.1. NP_981946.1. |
| UniGene | Hs.209983 |
3D structure databases | |
| SMR | P16949. Positions 6-141. |
| DisProt | DP00174. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P16949. 5 interactions. |
| STRING | P16949. |
PTM databases | |
| PhosphoSite | P16949. |
2-D gel databases | |
| SWISS-2DPAGE | P16949. |
| DOSAC-COBS-2DPAGE | P16949. |
| REPRODUCTION-2DPAGE | IPI00479997. |
Proteomic databases | |
| PeptideAtlas | P16949. |
| PRIDE | P16949. |
Genome annotation databases | |
| Ensembl | ENST00000357865; ENSP00000350531; ENSG00000117632; Homo sapiens. [Genome view] ENST00000374291; ENSP00000363409; ENSG00000117632; Homo sapiens. [Genome view] ENST00000399728; ENSP00000382633; ENSG00000117632; Homo sapiens. [Genome view] ENST00000455785; ENSP00000387858; ENSG00000117632; Homo sapiens. [Genome view] |
| GeneID | 3925. |
| UCSC | uc001bkz.1. human. |
Organism-specific databases | |
| CTD | 3925. |
| GeneCards | GC01M026099. |
| H-InvDB | HIX0000281. |
| HGNC | HGNC:6510. STMN1. |
| HPA | CAB010107. |
| MIM | 151442. gene. |
| PharmGKB | PA35491. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | P16949. |
| InParanoid | P16949. |
| OMA | KEAVPEF. |
| OrthoDB | EOG93BQ7P. |
| PhylomeDB | P16949. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | aurora_b_pathway. Aurora B signaling. p38gammadeltapathway. Signaling mediated by p38-gamma and p38-delta. |
Gene expression databases | |
| ArrayExpress | P16949. |
| Bgee | P16949. |
| CleanEx | HS_STMN1. |
| Genevestigator | P16949. |
| GermOnline | ENSG00000117632. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000956. Stathmin. [Graphical view] |
| PANTHER | PTHR10104. Stathmin. 1 hit. |
| Pfam | PF00836. Stathmin. 1 hit. [Graphical view] |
| PIRSF | PIRSF002285. Stathmin. 1 hit. |
| PRINTS | PR00345. STATHMIN. |
| PROSITE | PS00563. STATHMIN_1. 1 hit. PS01041. STATHMIN_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 15415. |
| SOURCE | Search... |
Entry information
| Entry name | STMN1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P16949 Secondary accession number(s): A2A2D1, B2R4E7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


